At diagnosis, breast cancer patients are categorized into different subtypes based on expression of three receptors: estrogen receptor-alpha (ERα), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (113–120). This evidence concerns the gene ERBB2 and breast carcinoma.